Phase 1 clinical trial of adoptive immunotherapy using “off-the-shelf” activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia

Autor: Boyiadzis, Michael *, Agha, Mounzer, Redner, Robert L., Sehgal, Alison, Im, Annie, Hou, Jing-Zhou, Farah, Rafic, Dorritie, Kathleen A., Raptis, Anastasios, Lim, Seah H., Wang, Hong, Lapteva, Natalia, Mei, Zhuyong, Butterfield, Lisa H., Rooney, Cliona M., Whiteside, Theresa L.
Zdroj: In Cytotherapy October 2017 19(10):1225-1232
Databáze: ScienceDirect
Externí odkaz: